Defining U.S. Vital Interests in Global Health
The AIDS epidemic and other global health issues addressed by 4 panelists representing
government, the pharmaceutical industry, educational and medical institutions.
Program Selections


The goal of this four-person panel is to review the relationship between global health and U.S. national interests. It explores the potential threats and opportunities that face the U.S. as a result of global health concerns, as well as potential U.S. foreign policy responses.

The panel also explores the potential opportunities for the U.S. pharmaceutical industry that could result from creative interventions into global health crises.

• Barry Bloom: Dean of the School of Public Health (7:44)

• Ken Bernard: Assistant Surgeon General (6:05)

• Raymond Gilmartin: CEO of Merck & Co. Inc. (8:36)

• Jeffrey Sachs: Professor and Macro-Economist (13:57)

• Reaction: Ken Bernard and Raymond Gilmartin (7:21)

• Question and Answer: Five Questions from the Audience

• Closing Statement by Dean Bloom (1:37)
Background Information
About the Panelists
About the Colloquium